Treatment, patterns of failure, and survival of patients with stage I nodal and extranodal non-Hodgkin's lymphomas, according to data in the population-based registry of the comprehensive cancer centre west

Cancer

Volumn 83, Issue 8, 1998, Pages 1612-1619

  Krol, Augustinus D ^a   Hermans, Jo ^b   Dawson, Lilian ^c   Snijder, Simone ^d   Wijermans, Pierre W ^e   Kluin Nelemans, Hanneke C ^c   Kluin, Philip M ^c   Van Krieken, J Han ^c   Noordijk, Evert M ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Integraal Kankercentrum West   (Netherlands)

^e LEYENBURG HOSPITAL   (Netherlands)

Author keywords

Extranodal; Nodal; Non Hodgkin's lymphoma; Patterns of dissemination; Prognosis

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT FAILURE;

BRAIN NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NETHERLANDS; POPULATION SURVEILLANCE; PROGNOSIS; REGISTRIES; REMISSION INDUCTION; RISK FACTORS; SPINAL CORD NEOPLASMS; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0032531864     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981015)83:8<1612::AID-CNCR17>3.0.CO;2-G     Document Type: Article

References (17)

1. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252-60.
2. Otter R, Gerrits WBJ, vd Sandt MM, Hermans J, Willemze R. Primary extranodal and nodal non-Hodgkin's Iymphoma: a survey of a population-based registry. Eur J Cancer Clin Oncol 1989;25:1203-10.
3. d'Amore F, Christensen BE, Brincker H, Pedersen NT, Thorling K, Hastrup J, et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin's lymphomas. Eur J Cancer 1991;27:1201-8.
4. Newton R, Ferlay J, Beral V, Devesa S. The epidemiology of non-Hodgkin's Iymphoma: comparison of nodal and extranodal sites. Int J Cancer 1997;72: 923-30.
5. Pals ST, Drillenburg P, Radaskicwicz T, Manten-Horst E. Adhesion molecules in the dissemination of non-Hodgkin's lymphomas. Acta Haematol 1997;97:73-80.
6. Raghoebier S, Kramer MHH, van Krieken JHJM, de Jong D, Limpens J, Kluin-Nelemans JC, et al. Essential differences in oncogene involvement between primary nodal and extranodal large cell Iymphoma. Blood 1991; 78:2680-5.
7. Non-Hodgkin's Iymphoma pathological classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and descriptions of a Working Formulation for clinical use. Cancer 1982;49,2112-35.
8. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, et al. A revised European American Classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361.
9. Hiddeman W, Longo DL, Coiffier B, Fisher RI, Cabanillas F, Cavalli F, et al. Lymphoma classification: the gap between biology and clinical management is closing. Blood 1996;88: 4085-9.
10. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971;31:1860-1.
11. Prestidge BR, Horning SJ, Hoppe RT. Combined modality therapy for stage I-II large cell lymphoma. Int J Radiat Oncol Biol Phys 1988;15:633-9.
12. Jones S, Miller TP, Connors JM. Long term follow-up and analysis for prognostic factors for patients with limited stage diffuse large cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy. J Clin Oncol 1989;9:1186-91.
13. Connors JM, Klimo P, Fairey RN, Voss N. Brief chemotherapy and involved field radiation therapy for limited stage, histologically aggressive lymphoma. Ann Intern Med 1987; 107:25-30.
14. Velasquez WS, Fuller LM, Jagannath S, Tucker SL, North LB, Hagemeister FB, et al. Stages I and II diffuse large cell lymphomas: prognostic factors and long term results with CHOP-Bleo and radiotherapy. Blood 1991;77:942-7.
15. Tondini C, Zanini M, Lombardi F, Bengala C, Rocca A, Giardini R, et al. Combined treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I and II histologically aggressive non-Hodgkin's lymphomas. J Clin Oncol 1993;11:720-5.
16. Isaacson PG. The MALT lymphoma concept updated. Ann Oncol 1995;6:319-20.
17. Krol ADG, Hermans J, Kramer MHH, Kluin PhM, Kluin-Nelemans JC, Blok P, et al. Gastric lymphomas compared with lymph node lymphomas in a population-based registry differ in stage distribution and dissemination patterns but not in patient survival. Cancer 1997; 79:390-7.